Skip to main content
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

Download the PDF
CNS

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.
Back to Top
Case Study

Autism Spectrum Disorder Study

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

CNS
Download the PDF

Challenge

ASD is a heterogeneous clinical condition, which makes it challenging to obtain clinical trial evidence for a targeted therapy. A biotech company aims to break down the one-size-fits-all approach to treating ASD and is seeking data to validate a more targeted strategy.

‍

Solution

  • ObvioHealth is conducting an observational trial that will identify and classify adults and adolescents with ASD according to different phenotypes—resulting in more homogeneous trial populations.
  • A follow-up study will evaluate the efficacy of a previously failed therapeutic on one of the sub-populations identified in the first study. The trial is being designed to reduce participant burden by including remote data capture.

‍

The study is ongoing at this time.

Discover More Case Studies

Discover More News

Discover More White Papers

Discover More Blogs

Discover More Playbooks

Discover More Webinars

Discover More Events

CNS

Sub-Clinical Mood Disorders

A government agency is aiming to identify digital biomarkers of depressive and anxious feelings. The agency needed to capture both objective and subjective data for analysis.

› Read More
CNS

ADHD Study

A biopharmaceutical company is seeking a Phase IV clinical trial to confirm the safety and efficacy of its ADHD therapeutic on a more real-world population. Phases I-III included narrow inclusion and exclusion criteria.

› Read More